Joseph Klein III, Director at Ionis Pharmaceuticals, sold IONS on Jul 1, 2026
Data as of Oct 16
- Traded
- Jul 1, 2026
- Disclosed
- Jul 6, 2026
- Filed
- 5 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
IONS since disclosure
−48.4%
after the sale
Similar stocks (XLV) since disclosure
+9.1%
XLV — its sector index fund
Change in closing price from Jul 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLJoseph Klein III DirectorIONS Ionis Pharmaceuticals Inc$903Kdisclosed Jul 6 · filed 5 days after the trade · late